ATE419256T1 - Salze oder komplexe von methylspendern mit phytinsäure oder derivaten davon und verfahren zu deren synthese - Google Patents
Salze oder komplexe von methylspendern mit phytinsäure oder derivaten davon und verfahren zu deren syntheseInfo
- Publication number
- ATE419256T1 ATE419256T1 AT06766355T AT06766355T ATE419256T1 AT E419256 T1 ATE419256 T1 AT E419256T1 AT 06766355 T AT06766355 T AT 06766355T AT 06766355 T AT06766355 T AT 06766355T AT E419256 T1 ATE419256 T1 AT E419256T1
- Authority
- AT
- Austria
- Prior art keywords
- phytic acid
- salts
- methyl donors
- complexes
- synthesis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/117—Esters of phosphoric acids with cycloaliphatic alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/541—Organic ions forming an ion pair complex with the pharmacologically or therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/12—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of acyclic carbon skeletons
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biochemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Psychiatry (AREA)
- Nutrition Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Seasonings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT000344A ITRM20050344A1 (it) | 2005-06-30 | 2005-06-30 | Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE419256T1 true ATE419256T1 (de) | 2009-01-15 |
Family
ID=39033793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06766355T ATE419256T1 (de) | 2005-06-30 | 2006-06-23 | Salze oder komplexe von methylspendern mit phytinsäure oder derivaten davon und verfahren zu deren synthese |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8293254B2 (enExample) |
| EP (1) | EP1896489B1 (enExample) |
| JP (2) | JP4589999B2 (enExample) |
| KR (1) | KR101346974B1 (enExample) |
| AT (1) | ATE419256T1 (enExample) |
| CY (1) | CY1108929T1 (enExample) |
| DE (1) | DE602006004588D1 (enExample) |
| DK (1) | DK1896489T3 (enExample) |
| ES (1) | ES2320489T3 (enExample) |
| IT (1) | ITRM20050344A1 (enExample) |
| PL (1) | PL1896489T3 (enExample) |
| PT (1) | PT1896489E (enExample) |
| SI (1) | SI1896489T1 (enExample) |
| WO (1) | WO2007004244A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20060026A1 (it) * | 2006-01-10 | 2007-07-11 | Truffini & Regge Farmaceutici Srl | Composizioni per uso rale a base di s-adenosilmetionina e processo per il loro ottenimento |
| ITMI20060629A1 (it) | 2006-03-31 | 2007-10-01 | Daniele Giovannone | Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento |
| CN101485118B (zh) | 2006-07-07 | 2017-05-31 | 艾利森电话股份有限公司 | 共存网络的资源分配 |
| ITMI20071374A1 (it) * | 2007-07-10 | 2009-01-11 | Gnosis Spa | Sali stabili di s-adenosilmetionina e processo per il loro ottenimento. |
| JP4598846B2 (ja) * | 2008-07-14 | 2010-12-15 | 磐田化学工業株式会社 | Ｓ−アデノシルメチオニン安定化のためのフィチン酸および／またはデキストリンを含む飲食用組成物 |
| IT1393331B1 (it) * | 2009-02-09 | 2012-04-20 | Graal S R L | Composizioni orosolubili e/o effervescenti contenenti almeno un sale di s-adenosilmetionina (same) |
| JP5573587B2 (ja) | 2010-10-20 | 2014-08-20 | 株式会社デンソー | 車両用回転電機 |
| ES2824807T3 (es) | 2013-01-16 | 2021-05-13 | Hebert Sam E Llc | Sales de indol-3-propionato estables de S-adenosil-L-metionina |
| ES2486441B1 (es) * | 2014-04-02 | 2015-06-11 | Universitat De Les Illes Balears | Preparaciones combinadas de acidificantes urinarios e inhibidores de la cristalización y su aplicación para el tratamiento o prevención de la litiasis renal fosfática o inducida por fosfato cálcico |
| EP3662919A1 (en) | 2015-08-31 | 2020-06-10 | Nutramax Laboratories, Inc. | Compositions comprising magnolia, phellodendron, theanine and/or whey protein |
| IT201700074957A1 (it) | 2017-07-04 | 2019-01-04 | Gnosis Spa | Sale di (ss)-adenosil metionina con inositolo esafosfato e procedimento per ottenerlo |
| FR3068602B1 (fr) * | 2017-07-10 | 2020-11-20 | Guy Parc | Nouveau traitement du cancer par une combinaison d'un derive phosphorique d'inositol et de chlorure de magnesium |
| EP3556398A1 (en) * | 2018-04-16 | 2019-10-23 | Croda Denmark A/S | Phytates for use as a biomolecules delivery or adsorption system |
| JP2021046375A (ja) * | 2019-09-19 | 2021-03-25 | ポッカサッポロフード＆ビバレッジ株式会社 | β３アドレナリン受容体活性化剤 |
| CN115572309B (zh) * | 2022-09-20 | 2024-05-03 | 浙江工业大学 | 一种高效阻燃、抗熔滴的环境友好型阻燃剂 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2824869A (en) * | 1954-08-04 | 1958-02-25 | Bristol Lab Inc | Salt of streptomycin and phytic acid |
| US3019226A (en) * | 1959-04-10 | 1962-01-30 | Olin Mathieson | Piperazine salt of phytic acid |
| US3242235A (en) * | 1963-06-13 | 1966-03-22 | Squibb & Sons Inc | Phytate salts of the tetracyclines |
| IE39517B1 (en) * | 1973-06-27 | 1978-10-25 | Bioresearch Sas | Double salts of s-adenosyl-l-methhionine |
| IT1200589B (it) * | 1985-02-14 | 1989-01-27 | Gibipharma Spa | Derivati naturali attivita farmagologica |
| JPH0215032A (ja) * | 1988-07-01 | 1990-01-18 | Sanwa Kagaku Kenkyusho Co Ltd | 肝疾患治療、予防剤及び強肝機能性飲食、し好物 |
| US5434144A (en) * | 1994-03-04 | 1995-07-18 | The Procter & Gamble Company | Methods of using cyclic polyanionic polyol derivatives for regulating skin wrinkles |
| IT1318535B1 (it) * | 2000-05-25 | 2003-08-27 | Chementecno Srl | Processo per la preparazione di sali farmaceuticamente accettabili di(ss,rs)-s-adenosil-l-metionina. |
| US20030069202A1 (en) * | 2000-06-02 | 2003-04-10 | Kern Kenneth Norman | Compositions, kits, and methods for promoting defined health benefits |
| US6610702B2 (en) | 2000-08-01 | 2003-08-26 | Gmp Oxycell, Inc. | Ammonium salts of inositol hexaphosphate, and uses thereof |
| JP2002145783A (ja) * | 2000-11-06 | 2002-05-22 | Kohjin Co Ltd | Ｓ−アデノシルメチオニンまたはその塩類を含有するカプセル製剤 |
| US20030078231A1 (en) * | 2001-06-22 | 2003-04-24 | Wilburn Michael D. | Orthomolecular sulpho-adenosylmethionine derivatives with antioxidant properties |
| WO2003087109A1 (en) * | 2002-04-12 | 2003-10-23 | Silbiotec Due S.A. | Medicaments containing glycerophosphoinositol-4-phosphate derivatives |
| US7135575B2 (en) * | 2003-03-03 | 2006-11-14 | Array Biopharma, Inc. | P38 inhibitors and methods of use thereof |
| AU2005271242B9 (en) * | 2004-08-12 | 2012-04-12 | Foresee Pharmaceuticals Co., Ltd. | Pharmaceutical compositions for controlled release delivery of biologically active compounds |
| US20060046982A1 (en) * | 2004-08-26 | 2006-03-02 | Waugh William H | Orthomolecular medical use of L-citrulline for capillary endothelial protection and adjacent cell protection in neurodegenerative disease |
-
2005
- 2005-06-30 IT IT000344A patent/ITRM20050344A1/it unknown
-
2006
- 2006-06-23 PT PT06766355T patent/PT1896489E/pt unknown
- 2006-06-23 DK DK06766355T patent/DK1896489T3/da active
- 2006-06-23 US US11/923,000 patent/US8293254B2/en active Active
- 2006-06-23 KR KR1020087001591A patent/KR101346974B1/ko active Active
- 2006-06-23 SI SI200630246T patent/SI1896489T1/sl unknown
- 2006-06-23 JP JP2008519145A patent/JP4589999B2/ja not_active Expired - Fee Related
- 2006-06-23 AT AT06766355T patent/ATE419256T1/de active
- 2006-06-23 WO PCT/IT2006/000484 patent/WO2007004244A1/en not_active Ceased
- 2006-06-23 PL PL06766355T patent/PL1896489T3/pl unknown
- 2006-06-23 ES ES06766355T patent/ES2320489T3/es active Active
- 2006-06-23 DE DE602006004588T patent/DE602006004588D1/de active Active
- 2006-06-23 EP EP06766355A patent/EP1896489B1/en active Active
-
2009
- 2009-03-26 CY CY20091100356T patent/CY1108929T1/el unknown
-
2010
- 2010-05-19 JP JP2010115119A patent/JP5283659B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| PT1896489E (pt) | 2009-04-01 |
| US8293254B2 (en) | 2012-10-23 |
| CY1108929T1 (el) | 2014-07-02 |
| DK1896489T3 (da) | 2009-04-20 |
| EP1896489A1 (en) | 2008-03-12 |
| KR101346974B1 (ko) | 2014-01-02 |
| ITRM20050344A1 (it) | 2007-01-01 |
| WO2007004244A1 (en) | 2007-01-11 |
| ES2320489T3 (es) | 2009-05-22 |
| JP5283659B2 (ja) | 2013-09-04 |
| EP1896489B1 (en) | 2008-12-31 |
| JP2010235616A (ja) | 2010-10-21 |
| DE602006004588D1 (de) | 2009-02-12 |
| PL1896489T3 (pl) | 2009-06-30 |
| JP2009500319A (ja) | 2009-01-08 |
| JP4589999B2 (ja) | 2010-12-01 |
| SI1896489T1 (sl) | 2009-06-30 |
| KR20080028949A (ko) | 2008-04-02 |
| US20090175914A1 (en) | 2009-07-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108929T1 (el) | Αλατα ή συμπλοκα δοτων μεθυλιου με φυτικο οξυ ή τα παραγωγα αυτου και μεθοδος για τη συνθεση αυτων | |
| DE602004030239D1 (de) | Verfahren und zwischenprodukte zur herstellung von (1r,2s,5s)-6,6-dimethyl-3-azabicycloä3,1,0 ühexan-2-carboxylaten oder salzen davon | |
| ATE493425T1 (de) | Verfahren zur herstellung ortho-metallierter metallverbindungen | |
| UA93225C2 (ru) | 3'-алкоксиспироциклопентилзамещенные производные тетрамовой кислоты и гербицидное средство ha их ochobe | |
| ATE534653T1 (de) | Metallkomplexe | |
| UY29261A1 (es) | Procedimiento para combatir enfermedades fúngicas en leguminosas | |
| BR112021006229A2 (pt) | composto, composição farmacêutica, e, método para tratamento de um câncer | |
| ATE447564T1 (de) | Zwischenprodukte für die herstellung von trans-5- chlor-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenzä , 3:6,7üoxepinoä4,5-cüpyrrol | |
| ATE556074T1 (de) | Neue imidazoä1,5-aüpyridinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese enthalten | |
| CY1112520T1 (el) | Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες | |
| AR058348A1 (es) | Derivados de 1-aza-biciclo-nonano y composiciones farmaceuticas que los comprenden | |
| UY28350A1 (es) | Productos aril-heteroaromaticos, composiciones que los contienen y su utilización | |
| AR064658A1 (es) | Proceso para preparar duloxetina y sus compuestos relacionados, asi como tambien intermediarios utiles en la misma | |
| WO2007120725A3 (en) | Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive | |
| UY29510A1 (es) | Derivados de urea, metodos para su fabricación, y usos de los mismos | |
| ATE465152T1 (de) | Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten | |
| ATE425961T1 (de) | Salze substituierter allophansaureester und deren verwendung in arzneimitteln | |
| DE602005020185D1 (de) | Verfahren zur herstellung von 17-hydroxy-6 beta, 7 beta, 15 beta,16 beta-bismethylen-17alpha-pregn-4henprodukte für dieses verfahren | |
| FR2906806B1 (fr) | Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant | |
| PH12019501980B1 (en) | Transition metal-catalyzed protodecarboxylation of alpha-halo-acrylic acid derivatives | |
| ATE529413T1 (de) | Verfahren zur synthese von aryloxydiaminopyrimidinen | |
| UY31515A1 (es) | Mezclas fungicidas | |
| ATE452881T1 (de) | Katalysiertes verfahren zur herstellung von c-5- substituierten heterocyclischen inhibitoren von 11beta-hydroxysteroiddehydrogenase vom typ 1 | |
| ATE528312T1 (de) | Verfahren zur synthese von makroliden | |
| MX2007013305A (es) | Nuevas tiazolidinonas sin nitrogeno basico, su produccion y su uso como agentes farmaceuticos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1896489 Country of ref document: EP |